DOJ SEAL
U.S. DEPARTMENT of JUSTICE CONTACT US A-Z INDEX
About » Office Locations » Headquarters » Headquarters News
HEADQUARTERS NEWS


Contact: DEA Public Affairs
(202) 307-7977


DEA’s Pharmacist Conference Supports 360 Drug Abuse Strategy

DEC 10 (WASHINGTON) - The United States Drug Enforcement Administration (DEA) is holding a Pharmacy Diversion Awareness Conference (PDAC) in Pittsburgh, Pa. December 10-11.  The conference is part of the DEA’s ongoing 360 Strategy to address prescription opioid and heroin abuse in Western Pennsylvania.  Hundreds of pharmacists from across Pennsylvania are expected to attend the conference jointly hosted by Demetra Ashley, DEA’s Associate Deputy Assistant Administrator for the Office of Diversion Control, and  Philadelphia Field Division Special Agent in Charge Gary Tuggle.

Special Agent in Charge Gary Tuggle of DEA's Philadelphia Field Division greets pharmacists attending the Pharmacy Diversion Awareness Conference being held today and tomorrow in Pittsburgh.  The conference is part of the agency's DEA 360 initiative to reduce heroin and meth use and trafficking in the city. DEA Headquarters Diversion Investigator Tom Prevoznik explains to pharmacists how the abuse of prescription painkillers, heroin use, and drug overdoses are linked.

Special Agent in Charge Gary Tuggle of DEA's Philadelphia Field Division greets pharmacists attending the Pharmacy Diversion Awareness Conference being held today and tomorrow in Pittsburgh.  The conference is part of the agency's DEA 360 initiative to reduce heroin and meth use and trafficking in the city.

DEA Headquarters Diversion Investigator Tom Prevoznik explains to pharmacists how the abuse of prescription painkillers, heroin use, and drug overdoses are linked.

“Eight out of ten new heroin users started by abusing prescription opioids,” said Tuggle in his opening remarks.  “Speaking with pharmacy personnel about the link between the non-medical use of prescription opioids and heroin abuse at the PDAC is a key component of the DEA 360 Strategy.”
 
The PDAC is a free training designed to assist pharmacists, pharmacy technicians, and loss prevention personnel employed by pharmacies, hospitals, and clinics in identifying and preventing diversion.  Today’s day-long session will be repeated tomorrow for a different group of attendees, doubling the number of registered pharmacists who can participate.

The diversion of prescription opioids, essentially abusing prescription narcotics, is a growing problem nationwide but also in Western Pennsylvania.  This diversion stems from various sources:  pharmacy robberies and thefts, forged prescriptions, doctor shopping, or illegitimate prescriptions from rogue practitioners. 

“Too many Americans—more than 46,000 a year—tragically die from drug overdoses, including from opioid painkillers and heroin,” Ashley added.  “DEA and Pennsylvania’s pharmacists working together can help to lower that number in this state.” 

On November 10, 2015, the DEA announced Pittsburgh as the first pilot city in the nation where the 360 Strategy would be implemented.  The goals of the 360 Strategy include stopping the deadly cycle of prescription opioid and heroin abuse by eliminating the drug trafficking organizations fueling violence on the streets and addiction in communities.  The strategy includes partnering with healthcare professionals as well as engaging and strengthening community and social service organizations that are best positioned to provide long-term help and support for building drug-free communities. 

For more on this PDAC or the 360 Strategy in Pennsylvania, contact DEA Public Information Officer/Special Agent Patrick J. Trainor at (215) 852-8740 or patrick.j.trainor@usdoj.gov
For more information on PDACs or pharmaceutical diversion in general, contact DEA Headquarters Public Affairs Officer Barbara Carreno at 202-307-7960 or barbara.l.carreno@usdoj.gov.


STAY CONNECTED

Receive E-mail Updates Receive E-mail Updates @DEAHQ Twitter Account button Hover @DEAHQ Twitter Account button Report Synthetic Drug Source button Hover Report Synthetic Drug Source button


Stay Connected Facebook Twitter YouTube

 

A-Z Index  Accessibility   Contact Us  Environmental Stewardship   FOIA  Legal Policies & Disclaimers  
No FEAR Act   Privacy Policy Plug-Ins USA.gov Whistleblower Protection